Clinical Trial Results
Discover the data behind NADEssence™. Our commitment to transparency ensures you have access to the rigorous testing and proven efficacy of our NAD+ formulations.
Observed within the first 5 days of daily supplementation.
Across randomized, double-blind, placebo-controlled clinical study.
Favorably impacted over 85 biomarkers and 65 metabolic pathways.

Clinically Relevant Outcomes with Use
Our study focused on intracellular increases in NAD+. There were 52 predefined clinical lab tests with 3,000 proteins and 1,500 metabolites observed. There were no statistically significant adverse findings indicating an excellent safety profile.
- check 52% Increase in treatment group versus placebo (4.5%).
- check Increased sirtuin 1 (SIRT1) activity.
- check Confirmed intracellular uptake in cellular mitochondria.
Liver, Kidney & Oxidative Stress
Results also supported an association between supplementation with NADEssence™ and improved liver and kidney functioning (decreased bilirubin, ALP, serum albumin and GGT) when compared to placebo. GGT, is also a marker of oxidative stress; reductions in GGT may indicate reduced oxidative stress.
"NADEssence™ stands out because it's built on mechanism, not marketing. The science, clinical intent, and manufacturing standards align with what healthcare professionals expect from a truly professional-grade product."
Clinical FAQ
What is NADEssence™ expand_more
How was the RENEWAL Study conducted? expand_more
Why you can rely on our measured results? expand_more
Is NADEssence™ FDA approved? expand_more
Where can I find more information? expand_more
Ready to ignite your cellular spark?
Join thousands of others experiencing the science-backed benefits of optimized NAD+ levels.